Compumedics Limited Overview
Get informed when a big investor buys or sells
+ Follow218.18
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Compumedics Limited's p/e ratio stands at 218.18. That is above the sector sector average of 27.12. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Compumedics Limited sits higher the its sector benchmark (27.12) with a P/E ratio of 218.18. That is roughly 704.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 218.18 is attractive depends on Compumedics Limited's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Compumedics Limited's P/E ratio evolved across reporting periods, while the comparison chart places CMP.AX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
